Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Effects of infection history on dengue virus infection and pathogenicity.

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr, Yang Y.

Nat Commun. 2019 Mar 18;10(1):1246. doi: 10.1038/s41467-019-09193-y.

2.

Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016).

Pavía-Ruz N, Barrera-Fuentes GA, Villanueva-Jorge S, Che-Mendoza A, Campuzano-Rincón JC, Manrique-Saide P, Rojas DP, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gómez-Dantés H.

PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006748. doi: 10.1371/journal.pntd.0006748. eCollection 2018 Nov.

3.

Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up.

Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H.

PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006847. doi: 10.1371/journal.pntd.0006847. eCollection 2018 Nov.

4.

Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic.

Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr, Vespignani A.

BMC Med. 2018 Oct 18;16(1):195. doi: 10.1186/s12916-018-1185-5.

5.

Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.

Zarnitsyna VI, Bulusheva I, Handel A, Longini IM, Halloran ME, Antia R.

PLoS One. 2018 Jun 26;13(6):e0199674. doi: 10.1371/journal.pone.0199674. eCollection 2018.

6.

Forecasting the effectiveness of indoor residual spraying for reducing dengue burden.

Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM.

PLoS Negl Trop Dis. 2018 Jun 25;12(6):e0006570. doi: 10.1371/journal.pntd.0006570. eCollection 2018 Jun.

7.

Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China.

Tsang TK, Chen TM, Longini IM Jr, Halloran ME, Wu Y, Yang Y.

Epidemiology. 2018 Sep;29(5):675-683. doi: 10.1097/EDE.0000000000000855.

PMID:
29847497
8.

DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.

Dean NE, Halloran ME, Longini IM.

Ann Appl Stat. 2018 Mar;12(1):330-347. doi: 10.1214/17-AOAS1095. Epub 2018 Mar 9.

9.

Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply.

Longini IM, Røttingen JA, Kieny MP, Edmunds WJ, Henao-Restrepo AM.

Lancet. 2018 Mar 17;391(10125):1021-1022. doi: 10.1016/S0140-6736(18)30559-2. Epub 2018 Mar 15. No abstract available.

PMID:
29565012
10.

Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico.

Bisanzio D, Dzul-Manzanilla F, Gomez-Dantés H, Pavia-Ruz N, Hladish TJ, Lenhart A, Palacio-Vargas J, González Roldan JF, Correa-Morales F, Sánchez-Tejeda G, Kuri Morales P, Manrique-Saide P, Longini IM, Halloran ME, Vazquez-Prokopec GM.

PLoS Negl Trop Dis. 2018 Mar 15;12(3):e0006298. doi: 10.1371/journal.pntd.0006298. eCollection 2018 Mar.

11.

Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico.

Pavía-Ruz N, Diana Patricia Rojas, Salha Villanueva, Granja P, Balam-May A, Longini IM, Halloran ME, Manrique-Saide P, Gómez-Dantés H.

Am J Trop Med Hyg. 2018 Apr;98(4):1202-1208. doi: 10.4269/ajtmh.17-0382. Epub 2018 Feb 15.

12.

Simulations for designing and interpreting intervention trials in infectious diseases.

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M.

BMC Med. 2017 Dec 29;15(1):223. doi: 10.1186/s12916-017-0985-3.

13.

Reply to Aguiar and Stollenwerk.

Yang Y, Meng Y, Halloran ME, Longini IM Jr.

Clin Infect Dis. 2018 Feb 1;66(4):642. doi: 10.1093/cid/cix883. No abstract available.

14.

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Nadlaou SD, Dean NE, Diallo A, Diallo A, Honora DA, Doumbia M, Enwere G, Higgs ES, Mauget T, Mory D, Riveros X, Oumar FT, Fallah M, Toure A, Vicari AS, Longini IM, Edmunds WJ, Henao-Restrepo AM, Kieny MP, Kéïta S.

Lancet Infect Dis. 2017 Dec;17(12):1276-1284. doi: 10.1016/S1473-3099(17)30541-8. Epub 2017 Oct 9. Erratum in: Lancet Infect Dis. 2017 Dec;17 (12 ):1232.

15.

Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.

Yang Y, Meng Y, Halloran ME, Longini IM Jr.

Clin Infect Dis. 2018 Jan 6;66(2):178-184. doi: 10.1093/cid/cix766.

16.

Spread of Zika virus in the Americas.

Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr, Vespignani A.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4334-E4343. doi: 10.1073/pnas.1620161114. Epub 2017 Apr 25.

17.

Controlling cholera in the Ouest Department of Haiti using oral vaccines.

Kirpich A, Weppelmann TA, Yang Y, Morris JG Jr, Longini IM Jr.

PLoS Negl Trop Dis. 2017 Apr 14;11(4):e0005482. doi: 10.1371/journal.pntd.0005482. eCollection 2017 Apr.

18.

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP.

Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Erratum in: Lancet. 2017 Feb 4;389(10068):504. Lancet. 2017 Feb 4;389(10068):504.

19.

Containing Ebola at the Source with Ring Vaccination.

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr, Halloran ME, Vespignani A.

PLoS Negl Trop Dis. 2016 Nov 2;10(11):e0005093. doi: 10.1371/journal.pntd.0005093. eCollection 2016 Nov.

20.

PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH.

Koepke AA, Longini IM Jr, Halloran ME, Wakefield J, Minin VN.

Ann Appl Stat. 2016 Jun;10(2):575-595. Epub 2016 Jul 22.

21.

Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis.

Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr, Halloran ME, Vespignani A.

BMC Med. 2016 Sep 7;14(1):130. doi: 10.1186/s12916-016-0678-3.

22.

The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016.

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM.

Euro Surveill. 2016 Jul 14;21(28). doi: 10.2807/1560-7917.ES.2016.21.28.30283.

23.

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.

Feldstein LR, Matrajt L, Elizabeth Halloran M, Keitel WA, Longini IM Jr; H5N1 Vaccine Working Group.

Vaccine. 2016 Jul 19;34(33):3796-802. doi: 10.1016/j.vaccine.2016.05.067. Epub 2016 Jun 20.

24.

Projected Impact of Dengue Vaccination in Yucatán, Mexico.

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM.

PLoS Negl Trop Dis. 2016 May 26;10(5):e0004661. doi: 10.1371/journal.pntd.0004661. eCollection 2016 May.

25.

Changes in the primary outcome in Ebola vaccine trial--Authors' reply.

Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ.

Lancet. 2016 Apr 9;387(10027):1509-10. doi: 10.1016/S0140-6736(16)00686-3. Epub 2016 Apr 7. No abstract available.

PMID:
27115974
26.

Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees.

Kenah E, Britton T, Halloran ME, Longini IM Jr.

PLoS Comput Biol. 2016 Apr 12;12(4):e1004869. doi: 10.1371/journal.pcbi.1004869. eCollection 2016 Apr.

27.

Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone.

Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr, Halloran ME, Cao WC.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4488-93. doi: 10.1073/pnas.1518587113. Epub 2016 Mar 28.

28.

Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection.

Dean NE, Halloran ME, Yang Y, Longini IM.

Clin Infect Dis. 2016 May 15;62(10):1277-1286. doi: 10.1093/cid/ciw114. Epub 2016 Feb 29. Review.

29.

Ebola vaccination - Authors' reply.

Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM; study steering group.

Lancet. 2015 Dec 19;386(10012):2480. doi: 10.1016/S0140-6736(15)00951-4. Epub 2015 Dec 18. No abstract available.

PMID:
26738716
30.

Correction: Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic.

Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr, Longini IM.

PLoS Negl Trop Dis. 2016 Jan 6;10(1):e0004377. doi: 10.1371/journal.pntd.0004377. eCollection 2016 Jan.

31.

One versus two doses: What is the best use of vaccine in an influenza pandemic?

Matrajt L, Britton T, Halloran ME, Longini IM Jr.

Epidemics. 2015 Dec;13:17-27. doi: 10.1016/j.epidem.2015.06.001. Epub 2015 Jun 22.

32.

Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic.

Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr, Longini IM.

PLoS Negl Trop Dis. 2015 Oct 21;9(10):e0004153. doi: 10.1371/journal.pntd.0004153. eCollection 2015. Erratum in: PLoS Negl Trop Dis. 2016 Jan;10(1):e0004377.

33.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA.

Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3.

PMID:
26248676
34.

The dengue vaccine pipeline: Implications for the future of dengue control.

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.

Vaccine. 2015 Jun 26;33(29):3293-8. doi: 10.1016/j.vaccine.2015.05.010. Epub 2015 May 16. Review.

35.

The contribution of neighbours to an individual's risk of typhoid outcome.

Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME.

Epidemiol Infect. 2015 Dec;143(16):3520-7. doi: 10.1017/S0950268815000692. Epub 2015 May 4.

36.

Vaccine testing. Ebola and beyond.

Lipsitch M, Eyal N, Halloran ME, Hernán MA, Longini IM, Perencevich EN, Grais RF.

Science. 2015 Apr 3;348(6230):46-8. doi: 10.1126/science.aaa3178. No abstract available.

37.

Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014.

Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.

Euro Surveill. 2015 Mar 12;20(10):21056.

38.

Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis.

Merler S, Ajelli M, Fumanelli L, Gomes MF, Piontti AP, Rossi L, Chao DL, Longini IM Jr, Halloran ME, Vespignani A.

Lancet Infect Dis. 2015 Feb;15(2):204-11. doi: 10.1016/S1473-3099(14)71074-6. Epub 2015 Jan 7.

39.

School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits.

Tran CH, Sugimoto JD, Pulliam JR, Ryan KA, Myers PD, Castleman JB, Doty R, Johnson J, Stringfellow J, Kovacevich N, Brew J, Cheung LL, Caron B, Lipori G, Harle CA, Alexander C, Yang Y, Longini IM Jr, Halloran ME, Morris JG Jr, Small PA Jr.

PLoS One. 2014 Dec 9;9(12):e114479. doi: 10.1371/journal.pone.0114479. eCollection 2014.

40.

Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.

Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3343. doi: 10.1371/journal.pntd.0003343. eCollection 2014 Dec.

41.

Household Transmission of Vibrio cholerae in Bangladesh.

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.

PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3314. doi: 10.1371/journal.pntd.0003314. eCollection 2014 Nov.

42.

Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic.

Poletto C, Gomes MF, Pastore y Piontti A, Rossi L, Bioglio L, Chao DL, Longini IM, Halloran ME, Colizza V, Vespignani A.

Euro Surveill. 2014 Oct 23;19(42). pii: 20936.

43.

Ebola: mobility data.

Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.

Science. 2014 Oct 24;346(6208):433. doi: 10.1126/science.346.6208.433-a. No abstract available.

44.

Emerging, evolving, and established infectious diseases and interventions.

Halloran ME, Longini IM Jr.

Science. 2014 Sep 12;345(6202):1292-4. doi: 10.1126/science.1254166.

45.

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM Jr, Wasserheit JN.

AIDS. 2013 Nov 13;27(17):2826-7. doi: 10.1097/QAD.0000000000000002. No abstract available.

PMID:
24384634
46.

The effects of vector movement and distribution in a mathematical model of dengue transmission.

Chao DL, Longini IM Jr, Halloran ME.

PLoS One. 2013 Oct 21;8(10):e76044. doi: 10.1371/journal.pone.0076044. eCollection 2013.

47.

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM Jr, Wasserheit JN.

AIDS. 2013 Sep 24;27(15):2494-6. doi: 10.1097/01.aids.0000432463.23508.a2. No abstract available.

PMID:
24029738
48.

Optimal vaccine allocation for the early mitigation of pandemic influenza.

Matrajt L, Halloran ME, Longini IM Jr.

PLoS Comput Biol. 2013;9(3):e1002964. doi: 10.1371/journal.pcbi.1002964. Epub 2013 Mar 21.

49.

Modeling cholera outbreaks.

Chao DL, Longini IM Jr, Morris JG Jr.

Curr Top Microbiol Immunol. 2014;379:195-209. doi: 10.1007/82_2013_307. Review.

50.

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM Jr, Wasserheit JN; HIV Viral Load Working Group.

AIDS. 2013 Mar 27;27(6):981-9. doi: 10.1097/QAD.0b013e32835cb927.

Supplemental Content

Loading ...
Support Center